Improvement Strategies of China's Pharmaceutical Price Policies from the Perspective of Innovation Incentive
ZHOU Bin1,2, WU Xiaoming1*
Improvement Strategies of China's Pharmaceutical Price Policies from the Perspective of Innovation Incentive
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |